Shelton Thomas, Nama Sharanya, Hall Orman, Williams Margaret
The Ohio State University College of Medicine, Columbus, OH, United States.
Department of Anesthesiology and Pain Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, United States.
Front Pharmacol. 2024 Mar 8;15:1335345. doi: 10.3389/fphar.2024.1335345. eCollection 2024.
Effective pain management is essential for optimal surgical outcomes; however, it can be challenging in patients with a history of opioid use disorder (OUD). Buprenorphine, a partial opioid agonist, is a valuable treatment option for patients with OUD. Initiating buprenorphine treatment in patients concurrently taking opioids can be complex due to potential adverse outcomes like precipitated withdrawal. Evolving guidelines suggest there are benefits to continuing buprenorphine for surgical patients throughout the perioperative period, however situations do arise when buprenorphine has been discontinued. Typically, in this scenario patients would be restarted on buprenorphine after they have fully recovered from post-surgical pain and no longer require opioids for pain control. Unfortunately, holding MOUD may expose the patient to risks such as opioid induced respiratory depression or addiction relapse. In this case series, we discuss a novel method to restart buprenorphine in small incremental doses, known as micro-dosing, while the patient is still taking opioids for pain. We will present two complex clinical cases when this method was used successfully at a tertiary care hospital system.
有效的疼痛管理对于实现最佳手术效果至关重要;然而,对于有阿片类药物使用障碍(OUD)病史的患者而言,这可能具有挑战性。丁丙诺啡作为一种部分阿片类激动剂,是治疗OUD患者的一种有价值的选择。在同时服用阿片类药物的患者中启动丁丙诺啡治疗可能会很复杂,因为可能会出现如戒断反应等潜在不良后果。不断发展的指南表明,在围手术期持续为手术患者使用丁丙诺啡是有益的,然而确实会出现丁丙诺啡已停药的情况。通常,在这种情况下,患者在从术后疼痛中完全恢复且不再需要阿片类药物控制疼痛后,会重新开始使用丁丙诺啡。不幸的是,停用药物维持治疗(MOUD)可能会使患者面临阿片类药物引起的呼吸抑制或成瘾复发等风险。在本病例系列中,我们讨论了一种在患者仍因疼痛服用阿片类药物时,以小剂量递增方式重新开始使用丁丙诺啡的新方法,即微剂量给药。我们将介绍在一家三级医疗医院系统成功使用该方法的两个复杂临床病例。